BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 15844462)

  • 1. [Pulmonary hypertension--classification and treatment: new guidelines].
    Bendayan D; Kramer MR
    Harefuah; 2005 Mar; 144(3):206-10, 229. PubMed ID: 15844462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging drugs for pulmonary hypertension.
    Girgis RE
    Expert Opin Emerg Drugs; 2010 Mar; 15(1):71-85. PubMed ID: 20095920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary arterial hypertension: new insights into the optimal role of current and emerging prostacyclin therapies.
    Waxman AB; Zamanian RT
    Am J Cardiol; 2013 Mar; 111(5 Suppl):1A-16A; quiz 17A-19A. PubMed ID: 23414683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Update: Current clinical developments in pulmonary hypertension].
    Dumitrescu D; Ghofrani HA; Grimminger F; Hoeper MM; Rosenkranz S
    Dtsch Med Wochenschr; 2009 Aug; 134 Suppl 5():S160-3. PubMed ID: 19718605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current treatment strategies for pulmonary arterial hypertension.
    Lee SH; Rubin LJ
    J Intern Med; 2005 Sep; 258(3):199-215. PubMed ID: 16115293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pulmonary arterial hypertension].
    Jaïs X; Sitbon O; Savale L; Montani D; Humbert M; Simonneau G
    Rev Prat; 2008 Nov; 58(18):1997-2010. PubMed ID: 19143271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [New international guidelines on pulmonary hypertension].
    Dinh-Xuan AT; Duong-Quy S
    Rev Mal Respir; 2010 Feb; 27(2):110-1. PubMed ID: 20206059
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of pulmonary hypertension with selective pulmonary vasodilators.
    Haj RM; Cinco JE; Mazer CD
    Curr Opin Anaesthesiol; 2006 Feb; 19(1):88-95. PubMed ID: 16547439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular pathophysiology and therapy of pulmonary hypertension.
    Olschewski H; Rose F; Grünig E; Ghofrani HA; Walmrath D; Schulz R; Schermuly R; Grimminger F; Seeger W
    J Lab Clin Med; 2001 Dec; 138(6):367-77. PubMed ID: 11753283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination pharmacotherapy in the treatment of pulmonary arterial hypertension: continuing education article.
    Tackett KL; Stajich GV
    J Pharm Pract; 2013 Feb; 26(1):18-28. PubMed ID: 23420762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodynamic effects of inhaled nitric oxide and phosphodiesterase inhibitor (dipyridamole) on secondary pulmonary hypertension following heart valve surgery in adults.
    Santini F; Casali G; Franchi G; Auriemma S; Lusini M; Barozzi L; Favaro A; Messina A; Mazzucco A
    Int J Cardiol; 2005 Aug; 103(2):156-63. PubMed ID: 16080974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary arterial hypertension.
    Murali S
    Curr Opin Crit Care; 2006 Jun; 12(3):228-34. PubMed ID: 16672782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New and future therapies in pulmonary arterial hypertension.
    Bull TM
    Semin Respir Crit Care Med; 2005 Aug; 26(4):429-36. PubMed ID: 16121320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Update in basic research in the therapy of pulmonary arterial hypertension].
    Schermuly R; Grimminger F
    Dtsch Med Wochenschr; 2008 Oct; 133 Suppl 6():S170-2. PubMed ID: 18814088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medical therapy for pulmonary arterial hypertension.
    Driscoll JA; Chakinala MM
    Expert Opin Pharmacother; 2008 Jan; 9(1):65-81. PubMed ID: 18076339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sarcoidosis-associated pulmonary hypertension: assessment and management.
    Palmero V; Sulica R
    Semin Respir Crit Care Med; 2010 Aug; 31(4):494-500. PubMed ID: 20665399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of pulmonary arterial hypertension].
    Jaïs X; Bonnet D
    Presse Med; 2010 Jun; 39 Suppl 1():1S22-32. PubMed ID: 20732614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current therapy of pulmonary hypertension.
    Baumhäkel M; Cremers B; Böhm M
    Herz; 2005 Jun; 30(4):303-10. PubMed ID: 15965807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term inhaled nitric oxide plus phosphodiesterase 5 inhibitors for severe pulmonary hypertension.
    Pérez-Peñate GM; Juliá-Serdà G; Ojeda-Betancort N; García-Quintana A; Pulido-Duque J; Rodríguez-Pérez A; Cabrera-Navarro P; Gómez-Sánchez MA
    J Heart Lung Transplant; 2008 Dec; 27(12):1326-32. PubMed ID: 19059113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination therapy with prostacyclin and tadalafil for severe pulmonary arterial hypertension: a pilot study.
    Bendayan D; Shitrit D; Kramer MR
    Respirology; 2008 Nov; 13(6):916-8. PubMed ID: 18811891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.